Correlation Between Bank of America and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank of America and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Bank of America and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Recursion Pharmaceuticals.
Diversification Opportunities for Bank of America and Recursion Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Bank and Recursion is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Bank of America i.e., Bank of America and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank of America and Recursion Pharmaceuticals
Considering the 90-day investment horizon Bank of America is expected to generate 1.5 times less return on investment than Recursion Pharmaceuticals. But when comparing it to its historical volatility, Bank of America is 3.69 times less risky than Recursion Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 672.00 in Recursion Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of 64.00 from holding Recursion Pharmaceuticals or generate 9.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank of America vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Bank of America |
| Recursion Pharmaceuticals |
Bank of America and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Recursion Pharmaceuticals
The main advantage of trading using opposite Bank of America and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Bank of America vs. Citigroup | Bank of America vs. Nu Holdings | Bank of America vs. HSBC Holdings PLC | Bank of America vs. Canadian Imperial Bank |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |